MD: Breast Cancer
Elizabeth Comen, MD is currently Assistant Attending in Breast Medicine Service at Memorial Sloan Kettering Cancer Center. Dr. Comen is a clinical investigator conducting translational research in collaboration with laboratories at the Sloan-Kettering Institute, Rockefeller University, and The Scripps Research Institute with both a clinical practice where she solely treat breast cancer patients with all stages of disease as well as research program. Dr. Comen's research projects are unified by an overall aim to improve the identification, prevention and treatment of breast cancer as well as elucidate mechanisms of metastasis and they are particularly focused on the role of the microenvironment and immune-mediated cells in moderating tumor growth and metastatic potential. Currently, she is the primary investigator on several protocols aimed at the elucidating the role of circulating exosomes, including miRNAs, and immune mediated cells in mediating metastasis for which she coordinates all the clinical efforts as well as integrate the experimental designs with input from pathology, surgical and laboratory colleagues. Dr. Comen earned her BA from Harvard College and her MD from Harvard Medical School. She completed residency at Mount Sinai Hospital and her fellowship at Memorial Sloan Kettering Cancer Center. She has presented her research many times at the American Society of Clinical Oncology (ASCO) Annual Meeting and the San Antonio Breast Cancer Symposium. She has also been awarded several peer-reviewed grants, including the Young Investigator Award from the Conquer Cancer Foundation of ASCO.